MORNING BID 🔸 $CVGW: Q4 EPS 5c vs. -2c last year; revenue up 19.5% to $170M vs. $161.93M est.; adj EBITDA $6.7M. 🔸 $GM: Multi-year deal with Vianode for synthetic graphite for EV batteries. 🔸 $TSLA: SEC sues Elon Musk for late disclosure of Twitter stake in 2022. 🔸 $VAL, $RIG, $NE, $HP, $SLB, $NOV: Downgraded to In Line from Outperform by Evercore/ISI. 🔸 $Oil Market: IEA reports 2025 oil surplus at 725k b/d, down from 950k b/d. 🔸 $Aluminum: Prices up slightly; EU eyes import limits from Russia, China's growth slows. 🔸 $PKE: Q3 EPS $0.08, sales $14.4M. 🔸 $BK: Q4 adj EPS $1.72 vs. $1.56 est.; AUM $2T; fee revenue +9% to $3.51B; net interest +8% to $1.19B; AUC/A $52.1T, up 9%. 🔸 $BHLB: Files for offering of up to 3.45M shares. 🔸 $BLK: Q4 adj EPS $11.93 vs. $11.22 est.; revenue +23% to $5.68B; AUM record $11.55T; operating margin 45.5%; $281B inflows Q4. 🔸 $DFS: Charge-off rate 2.55%, delinquency rate 1.76% at Dec 2024. 🔸 $JPM: Q4 EPS $4.81 vs. $4.04 est.; revenue $42.8B; charge-offs 1.63%, delinquencies 0.84%; FICC trading $5.01B vs. $4.37B est.; credit loss $2.63B; ROE 17%, ROTCE 21%; $486B inflows 2024. 🔸 $WFC: Q4 EPS $1.43 vs. $1.35 est.; net interest $11.84B; revenue $20.38B; commercial banking $3.17B, investment banking $4.61B, wealth management $3.96B. 🔸 $KROS: Paused dosing in TROPOS trial for pulmonary hypertension due to pericardial effusion concerns in safety review. 🔸 $VCEL: Lowers FY24 revenue forecast to $237M-$237.5M from $238M-$242M; raises gross margin to 72.5%; maintains EBITDA margin at 22%; Q4 revenue expected at $75.2M-$75.7M, under consensus. 🔸 $APLD: Q2 adj EPS ($0.06) vs. ($0.15) est.; EBITDA $21.4M vs. $19.68M est.; revenue $63.9M; cloud services +523% to $27.7M. 🔸 $PI: Maintains Q4 revenue and EBITDA guidance; expects EBITDA $13.6M-$15.1M, revenue $91M-$94M. 🔸 $LRCX: Downgraded to Peer Perform from Outperform by Wolfe Research. 🔸 $LASR: Q4 revenue forecast $46M-$48M, below $52M est.; lower than expected margins and EBITDA. 🔸 $MGNI: Expands partnership with Samsung Ads for programmatic ads in Southeast Asia. 🔸 $S: Downgraded to Neutral from Buy by UBS. 🔸 U.S. Policy: New regulations planned to limit chip exports to China from TSMC, Samsung, and others.

RECAP • $AMZN: Developing smart glasses for delivery drivers to aid navigation. • $ARMK: Q4 EPS $0.54 vs. $0.53 est., new $500M buyback, dividend up 11%, FY25 guidance increased. • $BLMN: Downgraded to Market Perform by Raymond James. • $BKNG: Announces organizational changes and layoffs. • $TSLA: Shares up 7% premarket, reached $1T market cap post-Trump win. • $ENPH: Cutting 17% of workforce, expects $17-20M in restructuring costs. • $NOV: Downgraded to Neutral by Citigroup, target price cut to $18. • $SMR: Filed for up to $200M share offering. • $Russia: Potential merger of major oil companies into one entity. • $FTX: Sued Binance & Zhao for $1.8B, also suing Scaramucci. • $GEHC & $RDNT: Collaborating on AI in imaging. • $INSP: $75M share repurchase program. • $TEVA: Seeking to reverse patent decision. • $TSM: Ordered to stop exporting advanced AI chips to China. • $SPNS: Reduced FY24 revenue forecast, Q3 underperformed. • $SONY: Q2 profit up 69%, game biz profits doubled, PS5 sales at 3.8M. • $PINS: Upgraded to Outperform by Wedbush.

#Downgrades - Nov 11, 2024 • $AGL: JMP Securities Downgrades to Market Perform from Market Outperform • $ALTM: Scotiabank Downgrades to Sector Perform from Sector Outperform - PT $5.85 • $ARDX: H.C. Wainwright Downgrades to Neutral from Buy - PT $5.50 • $ATMU: Wells Fargo Downgrades to Equal Weight from Overweight - PT $45 (from $42) • $BLMN: Raymond James Downgrades to Market Perform from Outperform • $CBT: JPMorgan Downgrades to Underweight from Neutral - PT $105 • $CE: BMO Capital Downgrades to Underperform from Market Perform - PT $76 (from $138) • $CE: UBS Downgrades to Neutral from Buy - PT $97 (from $161) • $GCMG: TD Cowen Downgrades to Hold from Buy - PT $15.50 • $IMCR: Mizuho Downgrades to Neutral from Outperform - PT $38 (from $72) • $MRK: Daiwa Securities Downgrades to Neutral from Outperform • $NOV: Citi Downgrades to Neutral from Buy - PT $18 (from $21) • $NRDY: JPMorgan Downgrades to Underweight from Neutral • $NVR: Seaport Global Securities Downgrades to Neutral from Buy • $PRA: Piper Sandler Downgrades to Neutral from Overweight - PT $18 • $RVTY: Nephron Downgrades to Sell from Sell - PT $105 • $SMAR: Guggenheim Downgrades to Neutral from Buy • $TDW: Raymond James Downgrades to Outperform from Strong Buy - PT $102 (from $131) • $TEM: Stifel Downgrades to Hold from Buy - PT $65 (from $45) • $VALE: UBS Downgrades to Neutral from Buy - PT $11.50 (from $14) • $WHF: Oppenheimer Downgrades to Perform from Outperform - PT $12 (from $14) • $XERS: Piper Sandler Downgrades to Neutral from Overweight - PT $3

#Downgrades - Sep 25, 2024 $EC: JPMorgan Downgrades to Underweight from Neutral - PT $8.50 (from $12) $EXPE: TD Cowen Downgrades to Hold from Buy - PT $150 $F: Morgan Stanley Downgrades to Equalweight from Overweight - PT $12 (from $16) $FOXA: CFRA Downgrades to Sell from Hold - PT $38 $FTRE: Jefferies Downgrades to Hold from Buy - PT $21 (from $25) $GM: Morgan Stanley Downgrades to Underweight from Equalweight - PT $42 (from $47) $GPN: BTIG Downgrades to Neutral from Buy $GPN: Seaport Global Securities Downgrades to Neutral from Buy $HBT: DA Davidson Downgrades to Neutral from Buy - PT $24 (from $26) $MEDP: Jefferies Downgrades to Hold from Buy - PT $345 (from $415) $MGA: Morgan Stanley Downgrades to Equalweight from Overweight $MNSO: DBS Group Downgrades to Hold from Buy - PT $13.30 $MNSO: JPMorgan Downgrades to Neutral from Overweight - PT $15 (from $27) $NOV: Wells Fargo Downgrades to Underweight from Equal Weight - PT $16 (from $20) $OSBC: DA Davidson Downgrades to Neutral from Buy - PT $17 (from $19) $PHIN: Morgan Stanley Downgrades to Equalweight from Overweight $RIVN: Morgan Stanley Downgrades to Equalweight from Overweight - PT $13 (from $16) $SMAR: BMO Capital Downgrades to Market Perform from Outperform - PT $56.50 (from $59) $SMAR: Canaccord Genuity Downgrades to Hold from Buy - PT $56.50 (from $60) $SMAR: Canaccord Genuity Downgrades to Hold from Buy - PT $56.50 (from $60) $SMAR: DA Davidson Downgrades to Neutral from Buy - PT $56.50 (from $55) $SMAR: William Blair Downgrades to Market Perform from Outperform $TSN: Piper Sandler Downgrades to Underweight from Neutral - PT $50 (from $57) $TXT: TD Cowen Downgrades to Hold from Buy - PT $95 (from $103) $UNP: Evercore ISI Downgrades to In Line from Outperform - PT $247 (from $254)